Related Experiment Video
Updated: Aug 18, 2026

High-Throughput Small Molecule Drug Screening For Age-Related Sleep Disorders Using Drosophila melanogaster
Published on: October 20, 2023
Melatonin excretion in normal children and in tuberous sclerosis complex with sleep disorder responsive to melatonin
Eleanor Hancock1, Finbar O'Callaghan, Judie English
1Department of Paediatrics, Royal United Hospital Bath NHS Trust, School of Health, University of Bath, Bath, UK.
Insights
Healthy children show normal melatonin excretion patterns, similar to those with tuberous sclerosis complex who respond to melatonin. This suggests melatonin may act as a simple sedative.
Area of Science:
- Pediatric Endocrinology
- Neuroscience
- Sleep Medicine
Background:
- Melatonin is a key hormone regulating sleep-wake cycles.
- Disrupted melatonin secretion is linked to sleep disorders in children.
- Tuberous Sclerosis Complex (TSC) is associated with sleep disturbances.
Purpose of the Study:
- To establish normal 6-sulfatoxymelatonin excretion patterns in healthy children.
- To compare these patterns with TSC patients experiencing sleep disorders responsive to melatonin.
- To investigate the potential mechanism of exogenous melatonin in improving sleep.
Main Methods:
- Measured 6-sulfatoxymelatonin excretion in 21 healthy children and 7 TSC patients.
- Analyzed total excretion, cosinor percentage, and acrophase time of melatonin metabolites.
- Administered a 5 mg oral dose of melatonin to TSC patients to assess sleep improvement.
Main Results:
- Healthy children exhibited a mean excretion of 19.0 microg (SD 7.4 microg) with a mean acrophase at 5:54 AM.
- Circadian rhythm (cosinor percentage) ranged from 52.9% to 100% (mean 87%).
- TSC patients who responded to melatonin displayed normal melatonin excretion patterns.
Conclusions:
- Normal melatonin excretion patterns were observed in healthy children and melatonin-responsive TSC patients.
- Circadian melatonin excretion patterns appear consistent between children and adults.
- Exogenous melatonin may exert its sleep-promoting effects through simple sedation.
Abstract:
To determine normal melatonin excretion patterns in healthy children without sleep disorder and to compare these with those of patients with tuberous sclerosis complex and sleep disorder responsive to exogenous melatonin, we measured 6-sulfatoxymelatonin excretion in 21 healthy children and in 7 patients with tuberous sclerosis complex and sleep disorder responsive to melatonin (a 5 mg oral dose increasing total sleep time). Total excretion, cosinor percentage, and acrophase time of 6-sulfatoxymelatonin excretion were estimated. In normal children, total 6-sulfatoxymelatonin excretion was range 11.1 to 40.2 microg (mean 19.0 microg, SD 7.4 microg); cosinor percentage rhythm range was 52.9% to 100% (mean 87%, median 94%); and acrophase time range was 23 hours, 54 minutes to 10 hours, 42 minutes (mean 5 hours, 54 minutes; median 4 hours, 12 minutes). Fifth and 95th percentiles were 11.1 to 29.0 microg, 57.8% to 99.9%, and 2 hours, 1 minute to 10 hours, 4 minutes. In tuberous sclerosis, normal patterns of melatonin excretion were seen in responders. Circadian patterns of melatonin excretion were similar in children and adults. We propose that exogenous melatonin can act by a simple sedative action.
Related Concept Videos
Management of Insomnia
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Pharmacokinetics in Pediatric Patients: Drug Excretion
Sleep-Wake Cycles
NREM Sleep
NREM sleep comprises four progressive stages that seamlessly merge:
Glucose Transporters
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:

